XML 19 R8.htm IDEA: XBRL DOCUMENT v3.25.3
UNAUDITED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Restricted shares
Restricted stock units
Total 
stockholders’
equity attributable to T. Rowe Price Group, Inc.
Total 
stockholders’
equity attributable to T. Rowe Price Group, Inc.
Restricted shares
Total 
stockholders’
equity attributable to T. Rowe Price Group, Inc.
Restricted stock units
Common
stock
Common
stock
Restricted shares
Common
stock
Restricted stock units
Additional
capital in
excess of
par value
Additional
capital in
excess of
par value
Restricted shares
Additional
capital in
excess of
par value
Restricted stock units
Retained
earnings
AOCI
 [1]
Non-controlling interests in consolidated entities
Beginning balance (in shares) at Dec. 31, 2023             223,938,000                
Balances at beginning of period at Dec. 31, 2023 $ 9,697.1     $ 9,505.1     $ 44.8     $ 431.7     $ 9,076.1 $ (47.5) $ 192.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net income (loss) 1,669.0     1,660.2                 1,660.2   8.8
Other comprehensive income (loss), net of tax 8.0     8.0                   8.0  
Dividends declared (850.7)     (850.7)                 (850.7)    
Common stock-based compensation plans activity:                              
Shares issued upon option exercises (in shares)             482,000                
Shares issued upon option exercises 30.5     30.5     $ 0.1     30.4          
Restricted shares issued, net of shares withheld for taxes (in shares)               7,000              
Restricted shares issued, net of shares withheld for taxes   $ (0.3)     $ (0.3)           $ (0.3)        
Net shares issued upon vesting of restricted stock units (in shares)                 64,000            
Net shares issued upon vesting of restricted stock units     $ (2.0)     $ (2.0)           $ (2.0)      
Stock-based compensation expense 162.2     162.2           162.2          
Restricted stock units issued as dividend equivalents                   0.3     (0.3)    
Common shares repurchased (in shares)             (2,348,000)                
Common shares repurchased (263.7)     (263.7)     $ (0.5)     (263.2)          
Net contributions to non-controlling interests in consolidated entities 2.6                           2.6
Ending balance (in shares) at Sep. 30, 2024             222,143,000                
Balances at end of period at Sep. 30, 2024 10,452.7     10,249.3     $ 44.4     359.1     9,885.3 (39.5) 203.4
Beginning balances attributable to redeemable non-controlling interests at Dec. 31, 2023 594.1                            
Increase (Decrease) in Temporary Equity [Roll Forward]                              
Net income (loss) 58.9                            
Other comprehensive income (loss), net of tax 6.2                            
Net subscriptions into T. Rowe Price investment products 361.0                            
Net deconsolidations of T. Rowe Price investment products (256.8)                            
Ending balances attributable to redeemable non-controlling interests at Sep. 30, 2024 763.4                            
Beginning balance (in shares) at Jun. 30, 2024             222,612,000                
Balances at beginning of period at Jun. 30, 2024 10,134.0     9,928.7     $ 44.5     368.8     9,564.6 (49.2) 205.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net income (loss) 601.0     603.0                 603.0   (2.0)
Other comprehensive income (loss), net of tax 9.7     9.7                   9.7  
Dividends declared (282.2)     (282.2)                 (282.2)    
Common stock-based compensation plans activity:                              
Shares issued upon option exercises (in shares)             187,000                
Shares issued upon option exercises 12.1     12.1           12.1          
Net shares issued upon vesting of restricted stock units (in shares)             8,000                
Net shares issued upon vesting of restricted stock units (0.2)     (0.2)           (0.2)          
Stock-based compensation expense 49.5     49.5           49.5          
Restricted stock units issued as dividend equivalents 0.0                 0.1     (0.1)    
Common shares repurchased (in shares)             (664,000)                
Common shares repurchased (71.3)     (71.3)     $ (0.1)     (71.2)          
Net contributions to non-controlling interests in consolidated entities 0.1                           0.1
Ending balance (in shares) at Sep. 30, 2024             222,143,000                
Balances at end of period at Sep. 30, 2024 10,452.7     10,249.3     $ 44.4     359.1     9,885.3 (39.5) 203.4
Beginning balances attributable to redeemable non-controlling interests at Jun. 30, 2024 689.0                            
Increase (Decrease) in Temporary Equity [Roll Forward]                              
Net income (loss) 37.4                            
Other comprehensive income (loss), net of tax 7.4                            
Net subscriptions into T. Rowe Price investment products 190.2                            
Net deconsolidations of T. Rowe Price investment products (160.6)                            
Ending balances attributable to redeemable non-controlling interests at Sep. 30, 2024 763.4                            
Beginning balance (in shares) at Dec. 31, 2024             222,966,000                
Balances at beginning of period at Dec. 31, 2024 10,506.1     10,345.4     $ 44.6     311.9     10,040.6 (51.7) 160.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net income (loss) 1,656.7     1,641.8                 1,641.8   14.9
Other comprehensive income (loss), net of tax 5.2     5.2                   5.2  
Dividends declared $ (858.7)     (858.7)                 (858.7)    
Common stock-based compensation plans activity:                              
Shares issued upon option exercises (in shares) 642,149           496,000                
Shares issued upon option exercises $ 31.6     31.6     $ 0.1     31.5          
Restricted shares issued, net of shares withheld for taxes (in shares)               8,000              
Restricted shares issued, net of shares withheld for taxes   $ (0.2)     $ (0.2)           $ (0.2)        
Net shares issued upon vesting of restricted stock units (in shares)                 23,000            
Net shares issued upon vesting of restricted stock units     $ (1.0)     $ (1.0)           $ (1.0)      
Stock-based compensation expense 134.2     134.2           134.2          
Restricted stock units issued as dividend equivalents                   0.4     (0.4)    
Common shares repurchased (in shares)             (4,809,000)                
Common shares repurchased (483.8)     (483.8)     $ (1.0)     (476.8)     (6.0)    
Net contributions to non-controlling interests in consolidated entities (5.6)                           (5.6)
Ending balance (in shares) at Sep. 30, 2025             218,684,000                
Balances at end of period at Sep. 30, 2025 10,984.5     10,814.5     $ 43.7     0.0     10,817.3 (46.5) 170.0
Beginning balances attributable to redeemable non-controlling interests at Dec. 31, 2024 944.0                            
Increase (Decrease) in Temporary Equity [Roll Forward]                              
Net income (loss) 105.9                            
Other comprehensive income (loss), net of tax 8.2                            
Net subscriptions into T. Rowe Price investment products 549.8                            
Net deconsolidations of T. Rowe Price investment products (623.0)                            
Ending balances attributable to redeemable non-controlling interests at Sep. 30, 2025 984.9                            
Beginning balance (in shares) at Jun. 30, 2025             219,902,000                
Balances at beginning of period at Jun. 30, 2025 10,713.8     10,560.5     $ 44.0     99.8     10,461.3 (44.6) 153.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net income (loss) 662.9     646.1                 646.1   16.8
Other comprehensive income (loss), net of tax (1.9)     (1.9)                   (1.9)  
Dividends declared (283.8)     (283.8)                 (283.8)    
Common stock-based compensation plans activity:                              
Shares issued upon option exercises (in shares)             232,000                
Shares issued upon option exercises 14.4     14.4     $ 0.0     14.4          
Net shares issued upon vesting of restricted stock units (in shares)             8,000                
Net shares issued upon vesting of restricted stock units (0.4)     (0.4)           (0.4)          
Stock-based compensation expense 37.3     37.3           37.3          
Restricted stock units issued as dividend equivalents 0.0                 0.3     (0.3)    
Common shares repurchased (in shares)             (1,458,000)                
Common shares repurchased (157.7)     (157.7)     $ (0.3)     (151.4)     (6.0)    
Net contributions to non-controlling interests in consolidated entities (0.1)                           (0.1)
Ending balance (in shares) at Sep. 30, 2025             218,684,000                
Balances at end of period at Sep. 30, 2025 10,984.5     $ 10,814.5     $ 43.7     $ 0.0     $ 10,817.3 $ (46.5) $ 170.0
Beginning balances attributable to redeemable non-controlling interests at Jun. 30, 2025 1,099.1                            
Increase (Decrease) in Temporary Equity [Roll Forward]                              
Net income (loss) 40.4                            
Other comprehensive income (loss), net of tax (2.8)                            
Net subscriptions into T. Rowe Price investment products 290.1                            
Net deconsolidations of T. Rowe Price investment products (441.9)                            
Ending balances attributable to redeemable non-controlling interests at Sep. 30, 2025 $ 984.9                            
[1] Accumulated other comprehensive income